Since RPE65 mutations in RPE affect rod function even at earliest disease stages, patients typically suffer from severe night blindness and severely reduced visual acuity and abnormal eye movements (nystagmus) from an early age on. This evidence concerns the gene RPE65 and pathologic nystagmus.